JP2003535050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003535050A5 JP2003535050A5 JP2001576000A JP2001576000A JP2003535050A5 JP 2003535050 A5 JP2003535050 A5 JP 2003535050A5 JP 2001576000 A JP2001576000 A JP 2001576000A JP 2001576000 A JP2001576000 A JP 2001576000A JP 2003535050 A5 JP2003535050 A5 JP 2003535050A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- channel blocker
- hypertrophy
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 208000031229 Cardiomyopathies Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- KEDQCFRVSHYKLR-UHFFFAOYSA-N 3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCN1C(=O)CC2=CC(OC)=C(OC)C=C2CC1 KEDQCFRVSHYKLR-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- OXTYVEUAQHPPMV-UHFFFAOYSA-N Alinidine Chemical compound ClC1=CC=CC(Cl)=C1N(CC=C)C1=NCCN1 OXTYVEUAQHPPMV-UHFFFAOYSA-N 0.000 description 1
- 229940123413 Angiotensin II antagonist Drugs 0.000 description 1
- 229950010767 alinidine Drugs 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229950003419 zatebradine Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10018401.4 | 2000-04-13 | ||
| DE10018401A DE10018401A1 (de) | 2000-04-13 | 2000-04-13 | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| PCT/EP2001/004034 WO2001078699A2 (de) | 2000-04-13 | 2001-04-07 | Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003535050A JP2003535050A (ja) | 2003-11-25 |
| JP2003535050A5 true JP2003535050A5 (https=) | 2006-02-23 |
| JP3905386B2 JP3905386B2 (ja) | 2007-04-18 |
Family
ID=7638652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001576000A Expired - Fee Related JP3905386B2 (ja) | 2000-04-13 | 2001-04-07 | 肥大を伴う心筋疾患の治療における徐脈剤の使用及び新規医薬組成物 |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7208508B2 (https=) |
| EP (2) | EP1666042A3 (https=) |
| JP (1) | JP3905386B2 (https=) |
| KR (1) | KR20020089453A (https=) |
| CN (1) | CN1245963C (https=) |
| AT (1) | ATE330588T1 (https=) |
| AU (2) | AU7048401A (https=) |
| BG (1) | BG65816B1 (https=) |
| BR (1) | BR0109996A (https=) |
| CA (2) | CA2404120C (https=) |
| CY (1) | CY1105081T1 (https=) |
| CZ (1) | CZ300549B6 (https=) |
| DE (2) | DE10018401A1 (https=) |
| DK (1) | DK1276476T3 (https=) |
| EA (1) | EA006977B1 (https=) |
| EE (1) | EE05099B1 (https=) |
| ES (1) | ES2266216T3 (https=) |
| HR (1) | HRP20020815A2 (https=) |
| HU (1) | HU228387B1 (https=) |
| IL (2) | IL152103A0 (https=) |
| ME (1) | MEP45908A (https=) |
| MX (1) | MXPA02009935A (https=) |
| NO (1) | NO330311B1 (https=) |
| NZ (1) | NZ521934A (https=) |
| PL (1) | PL215235B1 (https=) |
| PT (1) | PT1276476E (https=) |
| RS (1) | RS51478B (https=) |
| SI (1) | SI1276476T1 (https=) |
| SK (1) | SK286075B6 (https=) |
| TR (1) | TR200202326T2 (https=) |
| UA (1) | UA78679C2 (https=) |
| WO (1) | WO2001078699A2 (https=) |
| ZA (1) | ZA200208162B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10018401A1 (de) * | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| US20040138306A1 (en) * | 2002-07-25 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| EP1362590B1 (en) * | 2002-07-25 | 2004-01-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| KR20120058618A (ko) * | 2003-01-31 | 2012-06-07 | 다이이찌 산쿄 가부시키가이샤 | 동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약 |
| CA2613417C (en) * | 2005-06-27 | 2011-11-29 | Daiichi Sankyo Company, Limited | Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker |
| JPWO2007023775A1 (ja) * | 2005-08-23 | 2009-02-26 | アステラス製薬株式会社 | 心房細動治療剤 |
| EP1762179A1 (en) * | 2005-09-07 | 2007-03-14 | Boehringer Ingelheim Vetmedica Gmbh | Method for improving diagnostic quality in echocardiography |
| FR2894825B1 (fr) * | 2005-12-21 | 2010-12-03 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent |
| TWI399223B (zh) * | 2006-09-15 | 2013-06-21 | Daiichi Sankyo Co Ltd | 奧美沙坦酯及氨氯地平之固體劑型 |
| EP1908469A1 (en) * | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| EP2432452B1 (de) | 2009-05-20 | 2016-07-27 | Boehringer Ingelheim Vetmedica GmbH | Pharmazeutische telmisartan-trinklösung |
| FR2961105B1 (fr) | 2010-06-15 | 2013-02-08 | Servier Lab | Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque |
| KR101296743B1 (ko) * | 2011-02-17 | 2013-08-20 | 한국과학기술연구원 | 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법 |
| WO2013024036A1 (en) | 2011-08-12 | 2013-02-21 | Boehringer Ingelheim Vetmedica Gmbh | Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
| WO2014122248A1 (en) | 2013-02-11 | 2014-08-14 | Boehringer Ingelheim Vetmedica Gmbh | Kit-of-parts |
| PT3648761T (pt) | 2017-07-07 | 2024-06-05 | Boehringer Ingelheim Vetmedica Gmbh | Telmisartan para a profilaxia ou tratamento de hipertensão em gatos |
| KR20220054292A (ko) | 2019-07-09 | 2022-05-02 | 베링거잉겔하임베트메디카게엠베하 | 개의 고혈압 치료를 위한 텔미사르탄 |
| KR102398532B1 (ko) | 2020-07-20 | 2022-05-13 | 한림대학교 산학협력단 | 중증 지주막하출혈 진단용 조성물 |
| KR102331806B1 (ko) | 2020-07-20 | 2021-12-01 | 한림대학교 산학협력단 | 중증 지주막하출혈 진단용 바이오 마커 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759125A (fr) | 1969-11-19 | 1971-05-18 | Boehringer Sohn Ingelheim | Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer |
| DE3119874A1 (de) | 1981-05-19 | 1982-12-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" |
| DE3541811A1 (de) | 1985-11-27 | 1987-06-04 | Thomae Gmbh Dr K | Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5175157A (en) | 1985-11-27 | 1992-12-29 | Boehringer Ingelheim Gmbh | Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them |
| DE3736866A1 (de) | 1987-10-30 | 1989-05-11 | Thomae Gmbh Dr K | Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz |
| DE3805635A1 (de) | 1988-02-24 | 1989-09-07 | Thomae Gmbh Dr K | Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica |
| US5308853A (en) * | 1991-12-20 | 1994-05-03 | Warner-Lambert Company | Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties |
| RU2078536C1 (ru) * | 1993-09-02 | 1997-05-10 | Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско | Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией |
| CZ86796A3 (en) | 1993-09-24 | 1996-10-16 | Procter & Gamble | Novel deoxy and on oxygen substituted sugar derivatives of aminosteroidal compounds |
| US5595987A (en) * | 1994-07-22 | 1997-01-21 | The Trustees Of Columbia University In The City Of New York | Method of slowing ventricular arrhythmias using zatebradine |
| US6083991A (en) * | 1997-06-04 | 2000-07-04 | University Of Florida Research Foundation, Inc. | Anti-arrhythmic composition and methods of treatment |
| DE19741635A1 (de) | 1997-09-22 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| TR200100062T2 (tr) | 1998-07-10 | 2001-06-21 | Novartis Ag | Valsartan ve kalsiyum kanalı bloklayıcısının anti-hipertensif kombinasyonu |
| DE10018401A1 (de) | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| CA2435526A1 (en) | 2002-07-25 | 2004-01-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| US20040138306A1 (en) | 2002-07-25 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| EP1762179A1 (en) * | 2005-09-07 | 2007-03-14 | Boehringer Ingelheim Vetmedica Gmbh | Method for improving diagnostic quality in echocardiography |
-
2000
- 2000-04-13 DE DE10018401A patent/DE10018401A1/de not_active Withdrawn
-
2001
- 2001-04-07 KR KR1020027013688A patent/KR20020089453A/ko not_active Ceased
- 2001-04-07 AT AT01949281T patent/ATE330588T1/de active
- 2001-04-07 BR BR0109996-5A patent/BR0109996A/pt not_active Application Discontinuation
- 2001-04-07 ES ES01949281T patent/ES2266216T3/es not_active Expired - Lifetime
- 2001-04-07 EP EP06111485A patent/EP1666042A3/de not_active Withdrawn
- 2001-04-07 WO PCT/EP2001/004034 patent/WO2001078699A2/de not_active Ceased
- 2001-04-07 US US10/257,481 patent/US7208508B2/en not_active Expired - Fee Related
- 2001-04-07 PT PT01949281T patent/PT1276476E/pt unknown
- 2001-04-07 TR TR2002/02326T patent/TR200202326T2/xx unknown
- 2001-04-07 EE EEP200200590A patent/EE05099B1/xx not_active IP Right Cessation
- 2001-04-07 EA EA200201053A patent/EA006977B1/ru not_active IP Right Cessation
- 2001-04-07 DK DK01949281T patent/DK1276476T3/da active
- 2001-04-07 SI SI200130616T patent/SI1276476T1/sl unknown
- 2001-04-07 HR HRP20020815 patent/HRP20020815A2/hr not_active Application Discontinuation
- 2001-04-07 DE DE50110262T patent/DE50110262D1/de not_active Expired - Lifetime
- 2001-04-07 SK SK1458-2002A patent/SK286075B6/sk not_active IP Right Cessation
- 2001-04-07 MX MXPA02009935A patent/MXPA02009935A/es active IP Right Grant
- 2001-04-07 CA CA002404120A patent/CA2404120C/en not_active Expired - Fee Related
- 2001-04-07 ME MEP-459/08A patent/MEP45908A/xx unknown
- 2001-04-07 IL IL15210301A patent/IL152103A0/xx unknown
- 2001-04-07 AU AU7048401A patent/AU7048401A/xx active Pending
- 2001-04-07 AU AU2001270484A patent/AU2001270484B2/en not_active Ceased
- 2001-04-07 JP JP2001576000A patent/JP3905386B2/ja not_active Expired - Fee Related
- 2001-04-07 PL PL357827A patent/PL215235B1/pl unknown
- 2001-04-07 RS YUP-769/02A patent/RS51478B/sr unknown
- 2001-04-07 CZ CZ20023752A patent/CZ300549B6/cs not_active IP Right Cessation
- 2001-04-07 HU HU0300917A patent/HU228387B1/hu not_active IP Right Cessation
- 2001-04-07 CN CNB018079598A patent/CN1245963C/zh not_active Expired - Fee Related
- 2001-04-07 CA CA002575059A patent/CA2575059A1/en not_active Abandoned
- 2001-04-07 EP EP01949281A patent/EP1276476B1/de not_active Expired - Lifetime
- 2001-04-07 NZ NZ521934A patent/NZ521934A/en not_active IP Right Cessation
- 2001-07-04 UA UA2002118949A patent/UA78679C2/uk unknown
-
2002
- 2002-09-13 BG BG107103A patent/BG65816B1/bg unknown
- 2002-10-03 IL IL152103A patent/IL152103A/en not_active IP Right Cessation
- 2002-10-10 ZA ZA200208162A patent/ZA200208162B/en unknown
- 2002-10-11 NO NO20024924A patent/NO330311B1/no not_active IP Right Cessation
-
2006
- 2006-07-07 CY CY20061100956T patent/CY1105081T1/el unknown
-
2007
- 2007-03-12 US US11/684,974 patent/US20070155679A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003535050A5 (https=) | ||
| WO2002008186A3 (en) | Cyclopentanoindoles, compositions containing such compounds and methods of treatment | |
| WO2007129195A3 (en) | 4-pyrimidine-5-amino-pyrazole compounds | |
| DE50310614D1 (de) | Verfahren zur herstellung von c13-alkoholgemischen | |
| BRPI0000596B8 (pt) | composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto | |
| WO2004100875A3 (en) | Benzimidazoles, compositions containing such compounds and methods of use | |
| WO2007125405A3 (en) | Substituted 2-amino-fused heterocyclic compounds | |
| DOP2005000071A (es) | "compuestos de metil-aril o heteroaril-amida sustituida" | |
| WO2004062613A3 (en) | Hiv integrase inhibitors | |
| EA200601830A1 (ru) | Ортозамещённые арильные или гетероарильные амидные соединения | |
| WO2005002626A3 (en) | Therapeutic phosphonate compounds | |
| JP2002518389A5 (https=) | ||
| EP1423111A4 (en) | FXR NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS | |
| BRPI0507005A (pt) | compostos, composições farmacêuticas, uso de um composto, e, método de preparo de uma composição farmacêutica | |
| WO2007118205A3 (en) | Compounds, compositions and methods for treating hormone-dependent maladies | |
| WO2005103037A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| WO2005087771A3 (de) | 5,6-dialkyl-7-amino-triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel | |
| WO2005070884A3 (en) | Heterocyclic compounds useful as growth hormone secretagogues | |
| ATE373009T1 (de) | Verfahren zur vorbereitung von telithromycin | |
| WO2006122250A3 (en) | Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof | |
| EP1398029A8 (en) | NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives | |
| WO2005075450A3 (en) | Spiro-benzodioxoles and their use as cb1 antagonists | |
| CY1105039T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ | |
| WO2005005394A3 (en) | Thiophenylaminoimidazolines as prostaglandin i2 antagonists | |
| EA200501594A1 (ru) | Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора |